FTC sues major pharmacy benefit supervisors in excess of insulin rates The agency brought action against Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the record cost of lifetime-preserving insulin prescription drugs. Hear the posting 10 min This audio is car-created. Make sure https://dave-s-hot-chicken-nutrit83404.tokka-blog.com/30900106/considerations-to-know-about-healthcare-news